BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+18.89%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$26.5B
AUM Growth
+$26.5B
(+6.1%)
Cap. Flow
-$53.2M
Cap. Flow
% of AUM
-0.2%
Top 10 Holdings %
Top 10 Hldgs %
84.24%
Holding
134
New
14
Increased
16
Reduced
60
Closed
7
Top Buys
| 1 |
AbCellera Biologics
ABCL
|
$421M |
| 2 |
Kodiak Sciences
KOD
|
$224M |
| 3 |
NVTA
Invitae Corporation
NVTA
|
$159M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$61.5M |
| 5 |
Aligos Therapeutics
ALGS
|
$44.5M |
Top Sells
| 1 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$422M |
| 2 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$410M |
| 3 |
Exact Sciences
EXAS
|
$188M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
$20.2M |
| 5 |
AMRN
Amarin Corp
AMRN
|
$19.7M |
Sector Composition
| 1 | Healthcare | 97.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Spyre Therapeutics
SYRE
$1.02B
| $26.8M | 0.1% |
3,410,106
-969,486
| -22% | -$7.63M |
|
52
Fulgent Genetics
FLGT
$674M
| $25.8M | 0.1% |
495,573
-50,616
| -9% | -$2.64M |
|
53
Adaptive Biotechnologies
ADPT
$1.96B
| $22.5M | 0.08% |
379,682
-60,857
| -14% | -$3.6M |
|
54
Verastem
VSTM
$585M
| $21.6M | 0.08% |
+10,144,039
| New | +$21.6M |
|
|
MREO
55
Mereo BioPharma
MREO
$275M
| $21.6M | 0.08% |
+6,030,293
| New | +$21.6M |
|
56
Altimmune
ALT
$325M
| $21.3M | 0.08% |
1,884,451
-322,504
| -15% | -$3.64M |
|
57
Aurinia Pharmaceuticals
AUPH
$1.58B
| $19.5M | 0.07% |
1,410,064
-207,965
| -13% | -$2.88M |
|
58
Immatics
IMTX
$662M
| $19.5M | 0.07% |
1,805,025
+803,611
| +80% | +$8.67M |
|
59
Novavax
NVAX
$1.2B
| $18.9M | 0.07% |
169,706
-17,670
| -9% | -$1.97M |
|
|
ACGN
60
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $16.9M | 0.06% |
4,608,786
| – | – |
|
|
CBAY
61
DELISTED
Cymabay Therapeutics
CBAY
| $16.6M | 0.06% |
2,893,276
-359,266
| -11% | -$2.06M |
|
62
Xencor
XNCR
$594M
| $16.1M | 0.06% |
369,370
-40,772
| -10% | -$1.78M |
|
|
ALBO
63
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $15.5M | 0.06% |
412,466
-136,581
| -25% | -$5.12M |
|
64
Sangamo Therapeutics
SGMO
$161M
| $13.4M | 0.05% |
857,339
-92,484
| -10% | -$1.44M |
|
|
GWPH
65
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $13M | 0.05% |
112,897
-25,848
| -19% | -$2.98M |
|
|
GMDA
66
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $13M | 0.05% |
1,548,314
+914,990
| +144% | +$7.68M |
|
|
KDNY
67
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $11.9M | 0.04% |
+748,693
| New | +$11.9M |
|
|
FPRX
68
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $11.4M | 0.04% |
+668,000
| New | +$11.4M |
|
69
Mirum Pharmaceuticals
MIRM
$3.75B
| $11.3M | 0.04% |
647,313
+94,304
| +17% | +$1.65M |
|
70
ARS Pharmaceuticals
SPRY
$1.08B
| $11M | 0.04% |
+238,095
| New | +$11M |
|
71
Xenon Pharmaceuticals
XENE
$2.99B
| $10.6M | 0.04% |
687,386
-72,922
| -10% | -$1.12M |
|
|
BLUE
72
DELISTED
bluebird bio
BLUE
| $9.82M | 0.04% |
226,988
-25,012
| -10% | -$1.08M |
|
|
ISEE
73
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $9.72M | 0.04% |
1,406,037
| – | – |
|
74
Assembly Biosciences
ASMB
$183M
| $9.33M | 0.04% |
1,541,418
| – | – |
|
75
AnaptysBio
ANAB
$630M
| $9.18M | 0.03% |
427,179
-60,064
| -12% | -$1.29M |
|